These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11161386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
    Hanaoka N, Tanaka F, Wada H.
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):355-9. PubMed ID: 12457313
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T, Tanaka F, Takata T, Matsuoka K, Miyahara R, Otake Y, Yanagihara K, Fukushimab M, Wada H.
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FA, Pinedo HM, van Tinteren H, Giaccone G.
    Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
    Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC.
    Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
    [Abstract] [Full Text] [Related]

  • 13. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K.
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
    [Abstract] [Full Text] [Related]

  • 14. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
    Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P.
    Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640
    [Abstract] [Full Text] [Related]

  • 15. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
    Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O.
    J Clin Oncol; 2005 Apr 01; 23(10):2172-84. PubMed ID: 15800310
    [Abstract] [Full Text] [Related]

  • 16. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A, Nagaya M, Matsuoka H, Watanabe T, Tsukikawa S, Kubota S.
    Surgery; 2007 Nov 01; 142(5):741-8. PubMed ID: 17981195
    [Abstract] [Full Text] [Related]

  • 17. [Adjuvant chemotherapy for non-small cell lung cancer].
    Otake Y, Tanaka F, Wada H, Hitomi S.
    Gan To Kagaku Ryoho; 1997 Aug 01; 24(10):1245-51. PubMed ID: 9279343
    [Abstract] [Full Text] [Related]

  • 18. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
    Wang J, Liu X, Jiang W, Liang L.
    Chin Med J (Engl); 2000 Nov 01; 113(11):985-90. PubMed ID: 11776132
    [Abstract] [Full Text] [Related]

  • 19. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug 01; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 20. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.
    Eur J Cardiothorac Surg; 1998 Sep 01; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.